variables |  | patients with asymptomatic osteonecrosis n = 8 | patients without asymptomatic osteonecrosis n = 9 | Total n = 17 | P value |
---|---|---|---|---|---|
Age | Range | 27- 50 | 22- 46 | 22-50 | 0.321 |
Median (IQRa) | 39.5 (32.00- 47.00) | 31.00 (28.00- 43.00) | 39.00 (29.50- 43.00) | ||
Average rank | 10.38 | 7.78 | Â | ||
Gender | Maleb | 2 (25.00) | 3 (33.33) | 5 (29.41) | 0.583 |
Femaleb | 6 (75.00) | 6 (66.67) | 12 (70.59) | ||
Disease onset age | Range | 22—46 | 15—40 | 15- 46 | 0.046 |
Median (IQR) | 31.50 (28.25- 39.50) | 21.00 (18.50- 33.00) | 29.00 (20.50- 35.50) | ||
Average rank | 11.63 | 6.67 | Â | ||
Disease duration(year) | Range | 3- 10 | 1- 26 | 1 – 26 | 0.606 |
Median (IQR) | 5.50 (3.25- 8.75) | 6.00 (3.50- 18.00) | 6.00 (3.50- 9.50) | ||
Average rank | 8.25 | 9.67 | Â | ||
Organ involvement numbers | Range | 0 −3 | 0 −4 | 0 – 4 | 0.294 |
Median (IQR) | 2.33 (1.00- 2.75) | 2.00 (2.00- 3.00) | 2.00 (1.50—3.00) | ||
APS | Yesb | 0 (0) | 1 (0) | 1 (5.88) | 0.529 |
Hyperlipidemia | Yesb | 2 (25.00) | 1 (11.11) | 3 (17.65) | 0.453 |
Anti-dsDNA | Positiveb | 5 (62.50) | 5 (55.56) | 10 (58.82) | 0.581 |
CRP, ESR | Positiveb | 5 (62.50) | 2 (22.22) | 7 (41.18) | 0.117 |
Alcohol use | Yesb | 0 (0) | 0 (0) | 0 (0) | Â |